Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication August 3, 2004
- Accepted for publication March 17, 2005
- Published online May 25, 2005.
Article Versions
- Earlier version (May 4, 2005 - 10:41).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2005 American Society of Nephrology
Author Information
- Zhongxin Zhang*,
- Shahnaz Shahinfar*,
- William F. Keane†,
- Denise Ramjit*,
- Tania Z. Dickson‡,
- Gilbert W. Gleim‡,
- Carl Erik Mogensen§,
- Dick de Zeeuw‖,
- Barry M. Brenner¶ and
- Steven M. Snapinn*
- *Cardiovascular Clinical Research, †Clinical Development, and ‡Medical Communications Department, Merck & Co., Inc., West Point, Pennsylvania; §Medical Department, Aarhus University Hospital, Aarhus, Denmark; ‖Clinical Pharmacology, University Medical Center Groningen, Groningen, Netherlands; and ¶Renal Division, Brigham and Women’s Hospital, Boston, Massachusetts
- Address correspondence to:
Dr. Zhongxin Zhang, Merck & Co., Inc., P.O. Box 4, BL 3–4, West Point, PA 19486. Phone: 484-344-3871; Fax: 484-344-4000; E-mail: zhongxin_zhang{at}merck.com
Statistics from Altmetric.com
Article usage
Cited By...
Importance of Baseline Distribution of Proteinuria in Renal Outcomes Trials: Lessons from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Study
